Cargando…
Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
The emergence of the SARS-CoV-2 Omicron (B.1.1.529) variant with a surprising number of spike mutations raises concerns about reduced sensitivity of this virus to antibody neutralization and subsequent vaccine breakthrough infections. Here, we infect Moderna mRNA-vaccinated or previously infected ha...
Autores principales: | Halfmann, Peter J., Kuroda, Makoto, Maemura, Tadashi, Chiba, Shiho, Armbrust, Tammy, Wright, Ryan, Balaram, Ariane, Florek, Kelsey R., Bateman, Allen C., Kawaoka, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958134/ https://www.ncbi.nlm.nih.gov/pubmed/35421378 http://dx.doi.org/10.1016/j.celrep.2022.110688 |
Ejemplares similares
-
Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022) -
Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
por: Boon, Adrianus C. M., et al.
Publicado: (2022) -
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
por: Maemura, Tadashi, et al.
Publicado: (2021) -
SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021) -
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
por: Chiba, Shiho, et al.
Publicado: (2021)